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Abstract 
Aim: To investigate risk factors which impact on common carotid artery intima media 
thickness (IMT). 
Methods: A total of 86 obese children and adolescents and 22 healthy children and adoles-
cents with normal weight were enrolled. Moreover, 23 of 86 obese children and adolescents 
were diagnosed with metabolic syndrome (MetS). The clinical, biochemical data and the IMT 
of the common carotid artery were measured in all subjects. 
Results: Obese and obese with MetS subjects demonstrated a significantly (p < 0.01) thicker 
intima media (0.69mm, 0.66mm) as compared to the control group (0.38mm), but there was 
no significant difference of IMT between obese and MetS group. IMT was correlated to body 
weight, body mass index, waist circumference, waist to hip ratio, systolic blood pressure, 
diastolic blood pressure, fasting insulin, homoeostasis model assessment-insulin resistance, 
triglyceride, high-density lipoprotein- cholesterol, low-density lipoprotein-cholesterol, ala-
nine aminotransferase, aspartate aminotransferase and fatty liver. Waist circumference, waist 
to hip ratio, triglyceride and homoeostasis model assessment-insulin resistance were inde-
pendent determinants of mean IMT level.  
Conclusion: Obesity especially abdominal obesity, high TG and insulin resistance may be the 
main risk predictors of increased IMT. 
Key words: obesity, metabolic syndrome, intima-media thickness, children, adolescents 
Introduction 
The rapidly increasing prevalence of obesity 
among children is one of the most challenging prob-
lems. The prevalence of the metabolic syndrome 
(MetS) in children is increasing exponentially because 
of global increase in obesity. As indicated in previous 
studies [1,2,3], children and adolescents with risk 
factors such as obesity, dyslipidemia, elevated blood 
pressure and impaired glucose metabolism are at in-
creased risk of developing atherosclerosis in adult-
hood. It has been found that obesity results in the 
early onset of adulthood chronic disease such as car-
dio-cerebrovascular disease. Recent researches [4,5,6] 
have revealed that adiposity-associated inflammatory 
factors such as C-reactive protein (CRP), interleukin 
(IL)-6 and tumor necrosis factor (TNF)-α may play a 
role in promoting adverse vascular outcomes. 
The intima media thickness (IMT) of the com-
mon carotid artery (CCA) is a well-known marker of 
subclinical atherosclerosis and is a noninvasive, feas-
ible, reliable and inexpensive method for detecting 
development of subclinical atherosclerosis. Studies in 
adults have revealed that IMT was related to cardi-
ovascular risk factors and could predict the possibility 




IMT was also reported in children with obesity, fa-
milial hypercholesterolemia and nonalcoholic fatty 
liver disease (NAFLD) compared with control child-
ren. 
There has been no statistical data about the as-
sociation between IMT and the components of MetS 
since new definition for children and adolescent MetS 
was published by International Diabetes Federation 
(IDF). This study aimed to verify the relationships 
among obesity, dyslipidemia, elevated blood pres-
sure, impaired glucose metabolism, chronic inflam-
mation, fatty liver and IMT to explore as to which of 
these factors are related to IMT.  
Subjects and Methods 
Subjects  
A total of 86 obese Chinese children were 
enrolled from July 2008 to March 2009. The obese 
group was defined as obese children without MetS, 
which included 46 boys and 17 girls with a mean age 
of 10.5 ± 1.6 years (range 7.4 to 13.3 years). The MetS 
group was defined as obese children with MetS, 
which included 18 boys and 5 girls with a mean age of 
10.9 ± 1.6 years (range 7.6 to 14.2 years). Children with 
other chronic disease (endocrine disease, hereditary 
disease, or systemic inflammation) or those taking any 
medications were excluded. The control group con-
sisted of 22 healthy non-obese children, which in-
cluded 16 boys and 6 girls with a mean age of 11.1 ± 
2.1 years (ranging from 7.6 to 14.8 years). 
Consent was obtained from the parents and the 
Ethical Committee of the Children’s Hospital of Zhe-
jiang University School of Medicine.  
Diagnostic Criteria  
Obesity was defined as body mass index (BMI) 
≥95th percentile using the childhood date of Working 
Group on Obesity in China (WGOC) [9]. According to 
the IDF criteria for children and adolescents [10], 
MetS was identified if a subject had increased waist 
circumference ( > 90th percentile) [11] and also had ≥ 
2 of the following: 1) impaired fasting blood glucose ( 
≥ 5.6 mmol/L ), or Type 2 Diabetes Mellitus; 2) in-
creased blood pressure ( ≥ 130 mmHg systolic and/or 
≥ 85 mmHg diastolic ); 3) elevated plasma triglyce-
rides ( ≥ 1.7 mmol/L ); 4) high plasma high-density 
lipoprotein cholesterol ( < 1.03 mmol/L).  
Clinical characteristics  
The body weight was assessed using a calibrated 
standard balance beam, height was measured by a 
standard height bar, and BMI was calculated as body 
weight (kg) divided by square height (m2). Waist cir-
cumference (WC) was measured at the midway be-
tween the lower rib and the iliac crest, hip circumfe-
rence was measured at the widest part at the gluteal 
region. Systolic blood pressure (SBP) and diastolic 
blood pressure (DBP) were measured twice at the 
right arm after a 10-minute rest in the supine position 
using an automated sphygmomanometer.  
Biochemical measurements  
Samples were drawn between 8 and 9 am after 
fasting for 10 hours. Triglycerides (TG), total choles-
terol (TC) were measured by enzymatic and choles-
terol oxidase method respectively,  high plasma 
high-density lipoprotein cholesterol (HDL-C) and 
low-density lipoprotein cholesterol (LDL-C) were 
both detected by the direct assay method, alanine 
aminotransferase (ALT) and aspartate aminotransfe-
rase (AST) were tested by enzyme-linked immuno-
sorbent assay method. Fasting plasma glucose (FPG) 
was measured by glucose oxidase method; fasting 
plasma insulin (FINS) was measured by radioim-
munity assay (Modula Analytics PP, Roche). Both 
intra-assay and inter-assay coefficient of variations 
were less than 2.1% and 4.4%, respectively. Plasma 
l e v e l s  o f  I L - 6  a n d  T N F  w e r e  m e a s u r e d  b y  e n -
zyme-linked immunosorbent assay method (Ju Ying 
bioscitech, Shenzhen, China), with both intra-assay 
and inter-assay coefficient of variations being less 
than 10%.  
IMT measurement  
IMT was measured by B-mode ultrasound using 
a 10-MHz linear transducer (Philips HD7). The sub-
jects were examined supine with the neck extended 
and the probe in the antero-lateral position. All mea-
surements of IMT were made in the longitudinal 
plane at the point of maximum thickness on the far 
wall of the common carotid artery along a 1 cm sec-
tion of the artery proximal to the carotid bulb. The 
IMT was defined as the distance between the inti-
mia-blood interface and the adventitia-media junc-
tion. After freezing the image, the measurements were 
made using electronic calipers. The maximal thick-
nesses of the intima-media width were measured to 
give three readings and the mean value was used for 
statistical purposes. 
Statistical analysis  
Statistical analysis was performed with SPSS 
13.0. WHR, FBG, HOMA-IR, TNF were normalized by 
log-transformation. Statistically significant differences 
were tested for qualitative items by χ2 test and for 
quantitative items by One-Way ANOVA. Thereafter, 
associations were examined by Pearson correlation 
analysis for continuous variables, and by Spearman 




multiple stepwise linear regression analysis was used 
to examine relationships between mean IMT and all 
other variables investigated. A p<0.05 was considered 
statistically significant.  
Results 
The characteristics of three groups 
The obese and MetS group both demonstrated 
increased mean IMT, body weight, BMI, WC, WHR, 
SBP, FINS, HOMA-IR, lg (HOMA-IR), TG, LDL-C, 
ALT and AST levels, decreased HDL-C levels and 
higher prevalence of fatty liver (p < 0.05). Further-
more, the MetS group showed higher DBP compared 
with the control group. The children of MetS group 
had higher values of WC, SBP and TG, and lower 
HDL-C than these of obese group. There was no sta-
tistical difference in the age and sex among three 
groups (p = 0.400, 0.672), as shown in table 1. 
The relationship between IMT and all other va-
riables investigated  
In all subjects, mean IMT of CCA was signifi-
cantly related to body weight, BMI, WC, lg (WHR), 
SBP, DBP, FINS, lg (HOMA-IR), TG, HDL-C, LDL-C, 
ALT, AST and fatty liver, as shown in table 2. IMT 
was not significantly related to age, sex, FBG, TC, IL-6 
and lg (TNF).  
Finally, the multiple stepwise linear regression 
analysis showed that WC, lg (WHR), TG, lg 
(HOMA-IR) were independent determinants of mean 
IMT level. All the other factors were excluded in the 
equations, as shown in table 3.  
 
 
Table 1 The characteristics of obese, MetS and control groups 
  MetS group  Obese group  Control group  F/χ2 P  
Age(y)  10.9 ± 1.6  10.5 ± 1.6  11.1 ± 2.1  0.924 0.400 
Sex(F/M) 18/5  46/17  16/6  0.425 0.672 
Weight(kg) 70.15** 60.65**  31.86  96.045 <0.001 
BMI(kg/m2) 29.63** 28.04**  17.32  182.510 <0.001 
WC(cm) 94.22** # 88.83**  58.83  94.835 <0.001 
WHR 0.96** 0.96** 0.76 46.027  <0.001
lg(WHR) -0.02** -0.02** -0.12 40.424  <0.001
SBP(mmHg) 122.3** # 111.67** 103.32 15.079  <0.001
DBP(mmHg) 70.91** 67.06 63.14 6.994  0.002
FBG(mmol/L) 5.57 5.03 5.27 1.379  0.267
lg (FBG)  0.73 0.70 0.72 32.360  0.289
FINS(mmol/L) 29.36** 18.05** 5.62 32.237  <0.001
HOMA-IR 7.36** 4.20** 1.34 25.565  <0.001
lg (HOMA-IR)  0.72** # 0.50** 0.04 24.075  <0.001
TG(mmol/L) 2.53** ## 1.44** 0.95 27.587  <0.001
TC(mmol/L) 4.40 4.42 3.88 27.587  0.127
HDL-C(mmol/L) 0.94** ## 1.29** 1.54 37.089  <0.001
LDL-C(mmol/L) 2.94** 2.72** 2.05 9.566  <0.001
Fatty liver(%)  78.26** 58.73** 0.00 31.242  <0.001
ALT(mmol/L) 64.87** 61.17** 14.95 45.136  <0.001
AST(mmol/L) 39.83** 41.03** 24.41 50.953 0.001
IL-6(pg/ml) 5.06 4.32 4.26 1.982  0.143
TNF(pg/ml) 26.30  26.03 23.55 0.071  0.931
lg (TNF)  1.34 1.29 1.35 0.548  0.580
mean IMT(mm)  0.69** 0.66** 0.38 67.970  <0.001
BMI = body mass index; WC = waist circumference; WHR = waist to hip ratio; SBP = systolic blood pressure; DBP = diastolic blood pressure; 
FBG = fasting blood glucose; FINS = fasting insulin; HOMA-IR = homoeostasis model assessment- insulin resistance; TG = triglyceride; TC = 
total cholesterol; HDL-C = high-density lipoprotein- cholesterol; LDL-C = low-density lipoprotein-cholesterol; ALT = alanine aminotransfe-









Table 2 Correlation between mean IMT and all other variables 
Variable  Mean IMT 
r   p 
Age(y) 0.09  0.364 
Sex   0.01  0.935 
Weight(kg) 0.63  <0.001 
BMI(kg/m2) 0.68  <0.001 
WC(cm) 0.70  <0.001 
lg (WHR) 0.64  <0.001 
SBP(mmHg) 0.27  0.006 
DBP(mmHg) 0.21  0.033 
lg(FBG) -0.01  0.944 
FINS(mmol/L) 0.39  <0.001 
lg (HOMA-IR) 0.58  <0.001 
TG(mmol/L) 0.41  <0.001 
TC(mmol/L) 0.17  0.080 
HDL-C(mmol/L) -0.41  <0.001 
LDL-C(mmol/L) 0.28  0.004 
Fatty liver  0.35  <0.001 
ALT(mmol/L) 0.35  <0.001 
AST(mmol/L) 0.30  0.002 
IL-6(pg/ml) 0.17  0.082 
lg (TNF) 0.03  0.780 
BMI = body mass index; WC = waist circumference; WHR = waist to hip ratio; SBP = systolic blood pressure; DBP = diastolic blood pressure; 
FBG = fasting blood glucose; FINS = fasting insulin; HOMA-IR = homoeostasis model assessment- insulin resistance; TG = triglyceride; TC = 
total cholesterol; HDL-C = high-density lipoprotein- cholesterol; LDL-C = low-density lipoprotein-cholesterol; ALT = alanine aminotransfe-
rase; AST = aspartate aminotransferase; lg = logarithmical transformation. 
 
Table 3 Multiple stepwise linear regression analysis, with mean IMT of CCA as the dependent variable and all other va-









WC(cm) 0.003  0.292  0.001～0.005 0.009 
lg(WHR) 0.666  0.221  0.077～1.255 0.027 
TG(mmol/L) 0.038  0.222  0.014～0.062 0.002 
lg(HOMA-IR) 0.257  0.662  0.149～0.366 <0.001 




IMT is a well-known marker of subclinical 
a t h e r o s c e r o s i s  a n d  i t  a l s o  c a n  i n d i c a t e  f u t u r e  c a r -
dio-cerebrovascular disease [8,12,13]. Recent reports 
indicate that the presence of obesity in childhood is 
associated with increased adult IMT [2,3]. In our 
study we measured the IMT in obese and nonobese 
subjects. We found that IMT in obese children and 
adolescents was significantly increased as compared 
with non obese children of similar age and sex, which 
was in accordance with other studies [14,15,16]. This 
tendency was further intensified in the presence of 
MetS. IMT was closely associated with obesity espe-
cially abdominal obesity in childhood and adoles-
cence as confirmed by our correlation analysis and 
regression analysis.  
Obesity has been demonstrated to be associated 
with cardiovascular risk factors, such as hypertension, 
dyslipidemia, impaired glucose metabolism and 
chronic inflammation not only in adults but also in 
children and adolescents. In our study, IMT was sig-
nificantly related to lg (HOMA-IR) and TG in both 
bivariate correlation and multiple stepwise linear re-
gression analysis, suggesting a link between IMT, 
insulin resistance and dyslipidemia.  
Insulin resistance is a common phenomenon and 
plays an important role in the cardio-cerebrovascular 
disease in obese population [17,18]. In our study, the 
obese and MetS group both demonstrated increased 
fasting insulin than control group rather than fasting 
blood glucose. Meanwhile, fasting insulin and 
HOMA-IR levels were significantly related to IMT, 
however, fasting blood glucose was not related. This 
information demonstrates that an increased insulin 
levels seem to be an earlier predictor for atherogenic 
changes than hyperglycemia, and concur with data 




rectly stimulates the expression of vascular cell adhe-
sion molecule [20], but disrupts the balance between 
the production of NO and ET-1 leading to endothelial 
dysfunction [21]. Our regression analysis showed that 
lg (HOMA-IR) was an independent determinant of 
mean IMT level, which indicates that insulin resis-
tance was involved in the basic pathological changes 
associated of obesity [22], and was closely related to 
cardio-cerebrovascular disease.  
Dyslipidemia, especially low HDL-C and high 
LDL-C, or a high TG is related to car-
dio-cerebrovascular disease [23,24]. These risk factors 
association with IMT was also shown in our study. 
According to Pearson correlation analysis, HDL-C, 
LDL-C and TG were all related to IMT. Therefore, 
dyslipidemia and cardio-cerebrovascular disease 
were inseparable. In addition, prevalence of nonal-
coholic fatty liver in obese subjects with and without 
MetS was 78.26%, 58.73% respectively. In contrast, 
non obese children and adolescents had no fatty liver 
disease. The correlation between the fatty liver and 
IMT was significant. It was shown that nonalcoholic 
fatty liver disease (NAFLD) patients had an increase 
IMT compared with control subjects in children, just 
as many other studies have reported [25,26,27].  
Deficiencies still exist in our study. First, our 
sample size was not large enough, especially the 
number of MetS group. The levels of SBP, DBP, IL-6 
and TNF were not statistically related to IMT as other 
research [4,5,28,29,30]. However, the trend of increase 
was noted. This bias might due to the small sample 
size. Second, we used the standard of WC in Beijing 
rather than Zhe Jiang province, which might influence 
samples selection. Finally, the IMT may also probably 
be influenced by other risk factors which have not 
been tested in our study.  
In conclusion, atherosclerosis begins in obese 
children and adolescents, and this tendency is inten-
sified in the presence of MetS. Obesity especially ab-
dominal obesity, high TG level and insulin resistance 
are strong predictors of increased IMT.  
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